English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/127195
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Genetic variation in the tau kinases pathway may modify the risk and age at onset of alzheimer's disease

AuthorsVázquez-Higuera, José Luis; Valdivieso Amate, Fernando; Bullido, María Jesús ; Combarros, Onofre
KeywordsAlzheimer’s disease
Tau
Polymorphism
Phosphorylation
Kinases
Issue Date2011
PublisherIOS Press
CitationJournal of Alzheimer's Disease 27: 291- 297 (2011)
AbstractTau abnormal hyperphosphorylation and the formation of neurofibrillary tangles in the Alzheimer's disease (AD) brain is the result of upregulation of tau kinases. In a group of 729 Spanish late-onset AD patients and 670 healthy controls, we examined variations into a set of 20 candidate genes of kinases involved in tau phosphorylation at AD-related sites (PRKACB; CAMK2A; MARK1, 2, 3 and 4; CSNK1D; CDC2; RPS6KB1 and 2; p38α and β; IB1; JNK1, 2 and 3; MEK1 and 2; ERK1 and 2), to address hypotheses of genetic variation that might influence both AD risk and age at disease onset. There was an increased frequency of RPS6KB2 (intron 2, rs917570) minor allele in patients (50%) versus controls (39%) (OR = 1.52; 95% CI 1.30-1.77; p = 1.24 × 10 -5 Bonferroni corrected), and the presence of this minor allele was significantly (p = 4.2 × 10 -5) associated with a 3-years later onset of AD (mean age 74.1 years) when compared to age at onset of non-minor allele carriers (mean age 71.1 years). In APOE non-ε4 allele carriers, the combined effect of AD-associated risk alleles from the genes of CDC2, RPS6KB1 and 2, p38α, JNK (1, 2 and 3), MEK2, and ERK2 was significantly (p = 0.002) associated with a late-onset (>76 years) of AD. The CDC2 AGC haplotype derived from SNPs in introns 3 (rs2448347), 5 (rs2456772), and 7 (rs1871447) showed a protective effect against AD in APOE non-ε4 allele carriers (permutation p = 1.0 × 10 -4) with a frequency of 9% in cases and 15% in controls. Common genetic variation in the tau kinases pathway does underlie individual differences not only in susceptibility to AD but also in disease phenotype (age at disease onset).
URIhttp://hdl.handle.net/10261/127195
DOI10.3233/JAD-2011-110794
Identifiersdoi: 10.3233/JAD-2011-110794
issn: 1387-2877
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
Bullido MJ Genetic Variation.pdf231,74 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.